A recently published human clinical study demonstrates that Promentum® Recover, a patent-pending formula from FutureCeuticals anchored by calcium fructoborate in combination with low doses of turmeric ...
By Dennis Thompson HealthDay ReporterTHURSDAY, April 23, 2026 (HealthDay News) — A new gene therapy to treat inherited ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces the initiation of a Phase III clinical study of its proprietary Nectin-4-targeting ...
An FDA review of records in the U.S. clinical trials database shows that results have not been reported for 30% of clinical ...
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering next-generation gene therapies for inherited retinal diseases (IRDs) has today announced its participation in the ...
Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...
FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...
A newly published multicenter clinical study cites measurable improvements in cellulite and skin laxity using non-invasive ultrasound technology. It adds to a growing body of evidence around ...
Vera Clinic, internationally recognised as a leading centre of innovation in hair restoration surgery, has released the full ...
The search engine was released on April 13 and allows users to input details about their health history and find clinical ...
A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...
In the MAD phase, participants will receive once-daily oral dosing of NTX-253 or placebo for 10 consecutive days, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results